In this On-Demand version of the presentations, key opinion leaders from
Merck KGaA, Darmstadt, Germany
MilliporeSigma
, Hileman Laboratories Singapore, Baylor College of Medicine or Biofarma, provide a fascinating story of the behind of the scenes development of the recent pandemic and how long-term collaboration to optimize a neglected tropical disease vaccine platform transformed into the COVID-19 vaccine candidates.
Additionally, you will learn about:
- Technical transfer in vaccine manufacturing – including real world stories on bringing platforms to products
- Trends and costs in vaccine manufacturing – in both traditional and novel platforms.
- Applying Quality-by-Design concepts to vaccine manufacturing – finally, we will share information on how Quality by Design (QbD) is applied in vaccine manufacturing, including the principles and application. We will include case studies with a special feature of TFF technologies. Last, but not least, we will discuss the scale-up consideration using the QbD concept.
Be sure to register to view this valuable 2 1/2 hour lecture series
